Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|May 19, 2007
BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosisVarsha Tembe, Beric R Henderson
Cellular Signalling|March 30, 2007
Protein trafficking in response to DNA damageVarsha Tembe, Beric R Henderson
Pigment Cell & Melanoma Research|June 26, 2012
Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitorsRachael Anforth, Varsha Tembe, Tatiana Blumetti, et al.
The Journal of Biological Chemistry|January 6, 2005
Nuclear targeting and cell cycle regulatory function of human BARD1Stefan Schüchner, Varsha Tembe, José A Rodriguez, et al.
Prenatal Diagnosis|August 10, 2004
Issues arising from the prenatal diagnosis of some rare trisomy mosaics--the importance of cryptic fetal mosaicismArt Daniel, Zhanhe Wu, Artur Darmanian, et al.
The Journal of Investigative Dermatology|January 15, 2016
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic MelanomaKaushala Jayawardana, Sarah-Jane Schramm, Varsha Tembe, et al.
Pigment Cell & Melanoma Research|April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progressionGeorgina V Long, James S Wilmott, Lauren E Haydu, et al.
Molecular Cancer Therapeutics|September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicineJames S Wilmott, Varsha Tembe, Julie R Howle, et al.
Cellular Signalling|May 30, 2015
The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic functionVarsha Tembe, Estefania Martino-Echarri, Kamila A Marzec, et al.
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
Pageof 2